Physician profile
David E Cox
NPI 1740227925
$12,647.38
in general payments reported to CMS, 2019-2025
31 companies · $1,912 in 2025
The $1,912 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $176 · 2021: $827 · 2022: $4,656 · 2023: $3,519 · 2024: $1,030 · 2025: $1,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,252 · Travel and Lodging: $2,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,251.52 |
| Travel and Lodging | $2,209.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,480.92 | 2022-2025 | Venaseal, Symplicity G3 |
| Boston Scientific Corporation | $4,126.09 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Abbott Laboratories | $593.01 | 2019-2024 | Diamondback Peripheral, Jeti, Absolute Pro |
| Abiomed | $557.21 | 2019-2024 | Impella |
| Cardiovascular Systems INC. | $411.51 | 2022 | |
| Inari Medical, INC. | $324.41 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $263.76 | 2023-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $242.77 | 2024-2025 | |
| Amgen INC. | $237.88 | 2023-2025 | Repatha, Repatha |
| Biotronik INC. | $163.27 | 2019 | |
| Shockwave Medical, INC | $156.05 | 2021 | |
| Angiodynamics, INC. | $125.11 | 2022 | |
| Atricure, INC. | $98.60 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Cardinal Health 200 LLC | $95.07 | 2021 | |
| Chiesi USA, INC. | $84.50 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $79.59 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.97 | 2023-2025 | Jardiance |
| Novo Nordisk INC | $69.80 | 2025 | Wegovy |
| Pfizer INC. | $66.28 | 2019-2025 | |
| Stryker Corporation | $57.91 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Astrazeneca Pharmaceuticals Lp | $50.16 | 2024-2025 | Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.43 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $43.02 | 2020-2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $41.63 | 2023 | Uptravi, Opsumit |
| Lantheus Medical Imaging, INC. | $37.19 | 2022 | |
| Scpharmaceuticals INC. | $29.44 | 2023-2024 | |
| Cvrx, INC. | $21.29 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $21.04 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $20.29 | 2025 | Attruby |
| Philips North America LLC | $17.35 | 2019 | |
| Baxter Healthcare | $14.83 | 2024 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.